(BF-B) Brown-Forman - Ratings and Ratios
Whiskey, Bourbon, Tequila, Gin, Brandy
BF-B EPS (Earnings per Share)
BF-B Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 35.3% |
| Value at Risk 5%th | 54.6% |
| Relative Tail Risk | -5.86% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.80 |
| Alpha | -39.33 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.377 |
| Beta | 0.572 |
| Beta Downside | 0.528 |
| Drawdowns 3y | |
|---|---|
| Max DD | 63.94% |
| Mean DD | 33.28% |
| Median DD | 33.40% |
Description: BF-B Brown-Forman October 30, 2025
Brown-Forman (NYSE: BF-B) is a global producer and marketer of alcoholic beverages, covering a portfolio that spans whiskey (Jack Daniel’s, Woodford Reserve, Old Forester, Gentleman Jack), tequila (Herradura, el Jimador), gin (Fords Gin), Scotch malt (The Glendronach, Benriach, Glenglassaugh), and a range of ready-to-drink and bottled-in-bond products. The firm also generates ancillary revenue from used-barrel sales, bulk whiskey and wine, and contract bottling services, distributing through a mix of independent distributors, state and provincial governments, and direct retail channels across North America, Europe, Asia-Pacific and Latin America.
Key recent metrics (FY 2023): net sales of approximately $4.5 billion, an operating margin of ~22 % and free cash flow of $1.1 billion, reflecting strong premium-segment pricing power. The company’s growth is driven by continued “premiumization” trends-U.S. consumers are allocating a higher share of discretionary spend to higher-priced spirits, while emerging-market demand for tequila and ready-to-drink cocktails is expanding. A material risk factor is the sensitivity of sales to macro-economic cycles and regulatory changes (e.g., excise tax adjustments), which can compress margins if consumer spending tightens.
For a deeper, data-driven look at how these dynamics translate into valuation outlook, you might explore the detailed analyst models on ValueRay.
BF-B Stock Overview
| Market Cap in USD | 12,577m |
| Sub-Industry | Distillers & Vintners |
| IPO / Inception | 1984-09-07 |
| Return 12m vs S&P 500 | -39.1% |
| Analyst Rating | 3.0 of 5 |
BF-B Dividends
| Dividend Yield | 3.26% |
| Yield on Cost 5y | 1.22% |
| Yield CAGR 5y | 5.84% |
| Payout Consistency | 89.9% |
| Payout Ratio | 50.7% |
BF-B Growth Ratios
| CAGR 3y | -25.15% |
| CAGR/Max DD Calmar Ratio | -0.39 |
| CAGR/Mean DD Pain Ratio | -0.76 |
| Current Volume | 3993.7k |
| Average Volume | 3551.4k |
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (844.0m TTM) > 0 and > 6% of Revenue (6% = 236.9m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA 2.20pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 67.91% (prev 59.45%; Δ 8.46pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 741.0m <= Net Income 844.0m (YES >=105%, WARN >=100%) |
| Net Debt (2.23b) to EBITDA (1.25b) ratio: 1.78 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.79 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (473.0m) change vs 12m ago 0.00% (target <= -2.0% for YES) |
| Gross Margin 59.02% (prev 59.64%; Δ -0.63pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 48.22% (prev 49.86%; Δ -1.64pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 10.11 (EBITDA TTM 1.25b / Interest Expense TTM 115.0m) >= 6 (WARN >= 3) |
Altman Z'' 6.11
| (A) 0.33 = (Total Current Assets 4.18b - Total Current Liabilities 1.50b) / Total Assets 8.17b |
| (B) 0.57 = Retained Earnings (Balance) 4.67b / Total Assets 8.17b |
| (C) 0.14 = EBIT TTM 1.16b / Avg Total Assets 8.19b |
| (D) 1.09 = Book Value of Equity 4.55b / Total Liabilities 4.18b |
| Total Rating: 6.11 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 63.44
| 1. Piotroski 5.0pt = 0.0 |
| 2. FCF Yield 3.94% = 1.97 |
| 3. FCF Margin 14.79% = 3.70 |
| 4. Debt/Equity 0.68 = 2.28 |
| 5. Debt/Ebitda 1.78 = 0.42 |
| 6. ROIC - WACC (= 6.50)% = 8.12 |
| 7. RoE 21.77% = 1.81 |
| 8. Rev. Trend -67.96% = -5.10 |
| 9. EPS Trend 4.68% = 0.23 |
What is the price of BF-B shares?
Over the past week, the price has changed by +4.77%, over one month by +1.24%, over three months by -6.93% and over the past year by -30.14%.
Is Brown-Forman a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BF-B is around 20.37 USD . This means that BF-B is currently overvalued and has a potential downside of -26.91%.
Is BF-B a buy, sell or hold?
- Strong Buy: 2
- Buy: 3
- Hold: 10
- Sell: 3
- Strong Sell: 2
What are the forecasts/targets for the BF-B price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 30.8 | 10.5% |
| Analysts Target Price | 30.8 | 10.5% |
| ValueRay Target Price | 22.4 | -19.7% |
BF-B Fundamental Data Overview November 10, 2025
P/E Trailing = 14.8603
P/E Forward = 16.8919
P/S = 3.1856
P/B = 3.2813
P/EG = 3.9208
Beta = 0.41
Revenue TTM = 3.95b USD
EBIT TTM = 1.16b USD
EBITDA TTM = 1.25b USD
Long Term Debt = 2.08b USD (from longTermDebt, last quarter)
Short Term Debt = 626.0m USD (from shortTermDebt, last quarter)
Debt = 2.70b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.23b USD (from netDebt column, last quarter)
Enterprise Value = 14.81b USD (12.58b + Debt 2.70b - CCE 471.0m)
Interest Coverage Ratio = 10.11 (Ebit TTM 1.16b / Interest Expense TTM 115.0m)
FCF Yield = 3.94% (FCF TTM 584.0m / Enterprise Value 14.81b)
FCF Margin = 14.79% (FCF TTM 584.0m / Revenue TTM 3.95b)
Net Margin = 21.38% (Net Income TTM 844.0m / Revenue TTM 3.95b)
Gross Margin = 59.02% ((Revenue TTM 3.95b - Cost of Revenue TTM 1.62b) / Revenue TTM)
Gross Margin QoQ = 59.74% (prev 57.38%)
Tobins Q-Ratio = 1.81 (Enterprise Value 14.81b / Total Assets 8.17b)
Interest Expense / Debt = 0.93% (Interest Expense 25.0m / Debt 2.70b)
Taxrate = 22.73% (50.0m / 220.0m)
NOPAT = 898.7m (EBIT 1.16b * (1 - 22.73%))
Current Ratio = 2.79 (Total Current Assets 4.18b / Total Current Liabilities 1.50b)
Debt / Equity = 0.68 (Debt 2.70b / totalStockholderEquity, last quarter 3.99b)
Debt / EBITDA = 1.78 (Net Debt 2.23b / EBITDA 1.25b)
Debt / FCF = 3.82 (Net Debt 2.23b / FCF TTM 584.0m)
Total Stockholder Equity = 3.88b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.33% (Net Income 844.0m / Total Assets 8.17b)
RoE = 21.77% (Net Income TTM 844.0m / Total Stockholder Equity 3.88b)
RoCE = 19.54% (EBIT 1.16b / Capital Employed (Equity 3.88b + L.T.Debt 2.08b))
RoIC = 13.31% (NOPAT 898.7m / Invested Capital 6.75b)
WACC = 6.81% (E(12.58b)/V(15.28b) * Re(8.12%) + D(2.70b)/V(15.28b) * Rd(0.93%) * (1-Tc(0.23)))
Discount Rate = 8.12% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.75%
[DCF Debug] Terminal Value 77.15% ; FCFE base≈512.8m ; Y1≈484.2m ; Y5≈457.8m
Fair Price DCF = 26.61 (DCF Value 8.08b / Shares Outstanding 303.6m; 5y FCF grow -7.22% → 3.0% )
EPS Correlation: 4.68 | EPS CAGR: -9.24% | SUE: -0.14 | # QB: 0
Revenue Correlation: -67.96 | Revenue CAGR: -5.96% | SUE: 0.45 | # QB: 0
Additional Sources for BF-B Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle